Purchases and Sales Made in Q4 2024 in Pliant Therapeutics, Inc. (PLRX)
This table provides information about the institutional ownership of Pliant Therapeutics, Inc. (PLRX) during Q4 2024. The information is specifically focused on institutions that hold shares of PLIANT THERAPEUTICS, INC..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 14, 2025
Q4 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-17.5K- 1.25% |
$185K - $275K
|
1.39M
$1.68M
|
|
Feb 07, 2025
Q4 2024
|
Quest Partners LLC
New York, NY |
SELL
|
- |
-18.9K- 73.87% |
$199K - $297K
|
6.68K
$8.08K
|
|
Feb 14, 2025
Q4 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-22.1K- 14.01% |
$233K - $347K
|
136K
$164K
|
|
Feb 12, 2025
Q4 2024
|
Trexquant Investment LP
Stamford, CT |
SELL
|
- |
-24.4K- 28.06% |
$257K - $383K
|
62.5K
$75.6K
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-35.1K- 4.3% |
$371K - $551K
|
782K
$946K
|
|
Feb 14, 2025
Q4 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-38K- 28.16% |
$401K - $597K
|
97.1K
$117K
|
|
Feb 14, 2025
Q4 2024
|
Hudson Bay Capital Management LP
Greenwich, CT |
SELL
|
- |
-42.5K- 42.5% |
$448K - $667K
|
57.5K
$69.6K
|
|
Feb 14, 2025
Q4 2024
|
Exome Asset Management LLC
New York, NY |
SELL
|
- |
-46.1K- 30.81% |
$486K - $724K
|
104K
$125K
|
|
Feb 13, 2025
Q4 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-73.4K- 72.53% |
$774K - $1.15M
|
27.8K
$33.6K
|
|
Feb 13, 2025
Q4 2024
|
Fernwood Investment Management, LLC
Quincy, MA |
SELL
|
- |
-87.7K- 17.09% |
$925K - $1.38M
|
425K
$515K
|
|
Feb 14, 2025
Q4 2024
|
Polar Asset Management Partners Inc.
Toronto, A6 |
SELL
|
- |
-108K- 63.22% |
$1.14M - $1.69M
|
62.6K
$75.7K
|
|
Feb 13, 2025
Q4 2024
|
Adar1 Capital Management, LLC
Austin, TX |
SELL
|
- |
-111K- 45.23% |
$1.17M - $1.75M
|
135K
$163K
|
|
Feb 14, 2025
Q4 2024
|
Nuveen Asset Management, LLC
Chicago, IL |
SELL
|
- |
-129K- 38.31% |
$1.36M - $2.02M
|
207K
$250K
|
|
Feb 14, 2025
Q4 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-200K- 4.14% |
$2.11M - $3.15M
|
4.63M
$5.61M
|
|
Feb 14, 2025
Q4 2024
|
Granahan Investment Management, LLC
Waltham, MA |
SELL
|
- |
-211K- 28.6% |
$2.23M - $3.31M
|
527K
$638K
|
|
Feb 14, 2025
Q4 2024
|
Blue Owl Capital Holdings LP
New York, NY |
SELL
|
- |
-235K- 7.82% |
$2.48M - $3.69M
|
2.77M
$3.35M
|
|
Feb 11, 2025
Q4 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-298K- 8.44% |
$3.14M - $4.67M
|
3.23M
$3.91M
|
|
Feb 14, 2025
Q4 2024
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-302K- 9.45% |
$3.19M - $4.74M
|
2.9M
$3.5M
|
|
Feb 13, 2025
Q4 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-320K- 75.84% |
$3.37M - $5.02M
|
102K
$123K
|
|
Feb 14, 2025
Q4 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-507K- 80.73% |
$5.35M - $7.96M
|
121K
$146K
|
|
Feb 14, 2025
Q4 2024
|
Great Point Partners LLC
Greenwich, CT |
SELL
|
- |
-855K- 44.77% |
$9.02M - $13.4M
|
1.06M
$1.28M
|
|
Feb 14, 2025
Q4 2024
|
First Light Asset Management, LLC
Edina, MN |
SELL
|
- |
-894K- 34.73% |
$9.44M - $14M
|
1.68M
$2.03M
|